These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3510822

  • 1. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.
    Frith PA, Jenner B, Dangerfield R, Atkinson J, Drennan C.
    Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822
    [Abstract] [Full Text] [Related]

  • 2. Effects of inhaled oxitropium and fenoterol, alone and in combination, in chronic airflow obstruction.
    Frith PA, Jenner B, Atkinson J.
    Respiration; 1986 Feb; 50 Suppl 2():294-7. PubMed ID: 3563116
    [Abstract] [Full Text] [Related]

  • 3. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A, Nishimura K, Koyama H, Izumi T.
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma.
    Nishi K, Fujimura M, Myou S, Ooka T, Sakamoto S, Saitou M, Kasahara K, Matsuda T.
    Clin Auton Res; 1993 Feb; 3(1):41-4. PubMed ID: 8477180
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease.
    Koyama H, Nishimura K, Ikeda A, Izumi T.
    Chest; 1993 Dec; 104(6):1743-7. PubMed ID: 8252955
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects.
    Fujimura M, Kamio Y, Matsuda T, Hashimoto T.
    Clin Auton Res; 1993 Feb; 3(1):31-5. PubMed ID: 8477178
    [Abstract] [Full Text] [Related]

  • 10. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
    Suruda T, Nakamura H, Kobayashi H, Uetani K, Nishio M, Higashimoto Y, Funasako M, Ohata M.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
    [Abstract] [Full Text] [Related]

  • 11. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ.
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [Abstract] [Full Text] [Related]

  • 12. Comparison between fenoterol and fenoterol plus oxitropium bromide delivered by metered-dose inhaler with InspirEase to relieve acute asthma attack.
    Kamei T, Fujita J, Okada H, Nakamura H, Kishimoto T, Momoi A, Kawaji K, Yoshinouchi T, Ueda N, Takahara J.
    J Asthma; 1999 Sep; 36(1):67-75. PubMed ID: 10077137
    [Abstract] [Full Text] [Related]

  • 13. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G, Matera MG.
    Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dose-response study of oxitropium bromide inhaled as a nebulised solution.
    Stappaerts I, Van Schil L, Van der Veken J.
    Eur J Clin Pharmacol; 1994 Jun; 46(4):305-7. PubMed ID: 7957513
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The new anticholinergic bronchospasmolytic oxitropium bromide. Is long lasting protective effect through the night].
    Kneubühler HR, Kyd K, Benoit RC, Scherrer M.
    Schweiz Med Wochenschr; 1980 May 24; 110(21):812-6. PubMed ID: 7394499
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
    Cazzola M, Matera MG, Di Perna E, Califano C, D'Amato M, Mazzarella G.
    Respir Med; 1999 Dec 24; 93(12):909-11. PubMed ID: 10653054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.